Onyx Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Onyx Pharmaceuticals, Inc.
Quantité totale PI 15
Quantité totale incluant filiales 84 (+ 69 pour les filiales)
Rang # Quantité totale PI 103 158
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 242 237
Activité incl filiales 1,6/5.0    10
Parent Amgen Inc.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 1
1 4
3 1
3
 
Dernier brevet 2025 - Methods of treating multiple mye...
Premier brevet 1993 - Bcl-2 and r-ras complex
Dernière marque 2012 - KYPROLIS
Première marque 2001 - ONYX PHARMACEUTICALS

Filiales

1 subsidiaries with IP (69 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Methods of treating multiple myeloma using bcl-2 inhibitor. The present disclosure provides meth...
2022 Invention Compounds for proteasome enzyme inhibition. Peptide-based compounds including heteroatom-contain...
2021 Invention Peptide epoxyketone proteasome inhibitors in combination with pim kinase inhibitors for treatment...
Invention Methods of treating multiple myeloma. Provided herein are methods of treating a subject sufferin...
Invention Methods of treating multiple myeloma with a triplet therapy of carfilzomib, dexamethasone, and an...
2012 P/S Pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and he...
P/S Pharmaceuticals. Pharmaceutical research and development; medical and scientific research, namely...
P/S Pharmaceuticals for use in the field of oncology.
Invention Compounds for enzyme inhibition. Peptide-based compounds including heteroatom-containing, three-...
2011 Invention Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quin...
Invention Synthesis of cyclopentaquinazolines. A method of producing 6-amino-cyclopenta[g]quinazolines, in ...
P/S Human and veterinary pharmaceuticals for use in the prevention and treatment of cancer, oncology,...
2010 P/S Human pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors ...
2006 Invention Nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase. The present in...
Invention Candida kefyr cytosine deaminase. E. coli enzyme.
Invention Adenoviral vectors for treating diseases. Adenoviral vectors, including mutant adenoviruses, tha...
2004 Invention An oncolytic adenovirus. Viral vectors and methods of making such vectors are described that pref...
Invention Subgroup b adenoviral vectors for treating disease. Methods and compositions for treating diseas...
Invention Subgroup b adenoviral vectors for treating disease. Methods and compositions for treating disease...
Invention Method for purifying virus. A process for the purification of viruses from a cell lysate prepara...
Invention Method for purifying virus. A process for the purification of viruses from a cell lysate preparat...
2003 Invention Candida kefyr cytosine deaminase. A new cytosine deaminase gene and protein from Candida kefyr ar...
2002 Invention Nucleic acids and polypeptides which resemble rho and which interact with cell signalling pathway...
Invention Raf-mek-erk pathway inhibitors to treat cancer. Materials and methods for treating certain cancer...
Invention Adenoviral vectors for treating disease. Adenoviral vectors, including mutant adenoviruses, that ...
Invention Viral mutants that selectively replicate in targeted human cancer cells. Oncolytic viruses are de...
2001 Invention Phosphoinositide 3-kinases. The present invention relates PI3K crystals, polypeptide muteins, pol...
Invention Adenovirus e1b-55k single amino acid mutants and methods of use. Adenoviral mutants are described...
P/S Pharmaceuticals for use in the field of oncology. Medical and veterinary research and consultancy...
P/S Pharmaceuticals for use in the field of oncology.
Invention Method and reagent for the inhibition of checkpoint kinase-1 (chk1) enzyme. The present invention...
2000 Invention Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growt...
Invention Herpes simplex virus for treating unwanted hyperproliferative cell growth. The present invention ...
Invention Oncolytic adenovirus. Viral vectors and methods of making such vectors are described that prefere...
Invention Selection method for producing recombinant baculovirus. The present invention provides a novel me...
Invention Nucleotide sequences that encode phosphatidylinositol-3′ kinase associated proteins and uses ther...
Invention Phospholipase d polypeptide and dna sequences. Provided are novel phospholipase D DNA and amino a...
1999 Invention Adenovirus e1b shuttle vectors. Provided are replication competent, recombinant adenovirus vector...
Invention Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mut...
Invention Cell signaling polypeptides and nucleic acids. The present invention relates to an isolated SRK p...
Invention Nucleic acids and polypeptides which resemble rho and which interact with cell signaling pathways...
Invention Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase. The present in...
Invention Plasmids that encode green fluorescent protein. Methods and compositions for determining the tumo...
1998 Invention Compositions and methods for identifying pkb kinase inhibitors. Compositions and methods are desc...
1997 Invention Nucleic acid that encode a cell growth regulatory protein. Compositions of matter consisting of a...